相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC) - gastrointestinal cancer group
Eric Van Cutsem et al.
EUROPEAN JOURNAL OF CANCER (2008)
Capecitabine and oxaliplatin for advanced esophagogastric cancer
David Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
How do we improve outcomes for gastric cancer?
Khay-Guan Yeoh
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
Docetaxel and oxaliplatin combination in second-line treatment of patients with advanced gastric cancer
Carlo Barone et al.
GASTRIC CANCER (2007)
Multiple molecular mechanisms for multidrug resistance transporters
Christopher F. Higgins
NATURE (2007)
Estimates of the cancer incidence and mortality in Europe in 2006
J. Ferlay et al.
ANNALS OF ONCOLOGY (2007)
How can we best use structural information on P-glycoprotein to design inhibitors?
Christopher A. McDevitt et al.
PHARMACOLOGY & THERAPEUTICS (2007)
Multicenter phase II study of irinotecan, cisplatin, and bevacizumab in patients with metastatic gastric or gastroesophageal junction adenocarcinorna
Manish A. Shah et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: A report of the V325 study group
Eric Van Cutsem et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Pharmacological strategies for overcoming multidrug resistance
S. Nobili et al.
CURRENT DRUG TARGETS (2006)
Chemotherapy in advanced gastric cancer: A systematic review and meta-analysis based on aggregate data
Anna D. Wagner et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Body mass index and adenocarcinomas of the esophagus or gastric cardia: A systematic review and meta-analysis
Ai Kubo et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Alteration of genomic responses to doxorubicin and prevention of MDR in breast cancer cells by a polymer excipient: Pluronic P85
Elena V. Batrakova et al.
MOLECULAR PHARMACEUTICS (2006)
The translocation mechanism of P-glycoprotein
R Callaghan et al.
FEBS LETTERS (2006)
Multidrug resistance: Retrospect and prospects in anti-cancer drug treatment
Ricardo Perez-Tomas
CURRENT MEDICINAL CHEMISTRY (2006)
Meta-analysis: Obesity and the risk for gastroesophageal reflux disease and its complications
H Hampel et al.
ANNALS OF INTERNAL MEDICINE (2005)
The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence
H Pohl et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Effect of pluronic p85 on ATPase activity of drug efflux transporters
EV Batrakova et al.
PHARMACEUTICAL RESEARCH (2004)
Phase II study of irinotecan and 5-fluorouracil/leucovorin in patients with primary refractory or relapsed advanced oesophageal and gastric carcinoma
L Assersohn et al.
ANNALS OF ONCOLOGY (2004)
Oesophageal cancer: new developments in systemic therapy
DH Ilson
CANCER TREATMENT REVIEWS (2003)
Mechanism of sensitization of MDR cancer cells by Pluronic block copolymers: Selective energy depletion
EV Batrakova et al.
BRITISH JOURNAL OF CANCER (2001)
Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries
AAM Botterweck et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2000)
分享论文
